Hymenoptera venom

Hymenoptera venom is a complex biological mixture produced by stinging insects such as bees, wasps, hornets, and ants. It comprises a diverse array of bioactive compounds, including enzymes, peptides, and biogenic amines, which vary in composition across different species. These components exert potent biological effects, ranging from localized pain and inflammation to systemic allergic reactions, including life-threatening anaphylaxis. Key allergenic proteins like phospholipase A2, hyaluronidase, and antigen 5 are responsible for IgE-mediated hypersensitivity. The venom's neurotoxic and cytolytic peptides contribute to its immediate effects, while other components can modulate immune responses. In susceptible individuals, exposure to Hymenoptera venom can trigger severe allergic reactions, making it a significant public health concern. Management of these reactions involves immediate treatment with epinephrine for anaphylaxis, and long-term prevention through venom immunotherapy (VIT). VIT works by inducing immune tolerance, shifting the immune response and generating protective antibodies. Biomarkers such as specific IgE levels and serum tryptase are crucial for diagnosis and monitoring. Safety concerns primarily revolve around the risk of anaphylaxis and potential adverse reactions during immunotherapy, particularly in patients with underlying health conditions.

Other names

VenomPoisonToxinStingSecretionBee venomWasp venomAnt venom

Hymenoptera venom itself is a complex mixture, not a single target with a mechanism of action for drugs. However, drugs interacting with the venom or its effects have the following mechanisms: Epinephrine counteracts anaphylaxis by causing vasoconstriction and bronchodilation. Antihistamines block the effects of histamine, reducing itching and inflammation. Corticosteroids reduce inflammation. Venom immunotherapy (VIT) induces immune tolerance by generating allergen-specific regulatory T (Treg) cells, suppressing IgE production, inducing blocking IgG4 antibodies, decreasing basophil responsiveness, and shifting the immune response from a Th2 to a Th1 profile.